Insulin treatment improves liver histopathology and decreases expression of inflammatory and fibrogenic genes in a hyperglycemic, dyslipidemic hamster model of NAFLD

Abstract Background Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are highly prevalent comorbidities in patients with Type 2 diabetes. While many of these patients eventually will need treatment with insulin, little is known about the effects of insulin treatment...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Victoria Svop Jensen, Christian Fledelius, Christina Zachodnik, Jesper Damgaard, Helle Nygaard, Kristina Steinicke Tornqvist, Rikke Kaae Kirk, Birgitte Martine Viuff, Erik Max Wulff, Jens Lykkesfeldt, Henning Hvid
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2021-02-01
Colecção:	Journal of Translational Medicine
Assuntos:	NAFLD NASH Non-alcoholic fatty liver disease Non-alcoholic steatohepatitis Animal models Hamster
Acesso em linha:	https://doi.org/10.1186/s12967-021-02729-1
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!